proteins that bind the duplex and single-strand regions that also have altered telomeric sequences results in of the telomere and contribute to the unique non-nucleocompletely unregulated telomere elongation, whereas somal chromatin structure called the telosome. The first either mutant situation alone has only minor effects on well-characterized telomere proteins, from the ciliates telomere length regulation. Oxytricha and Euplotes, have been shown to bind tenaThe paradigm of a negative regulator of telomere elonciously to the G-rich single-strand extension found at gation was further underscored by experiments from the the end of the chromosome (reviewed by Fang and fission yeast, S. pombe. T. Cech (University of Colorado, Cech, 1995) . In addition to these end-binding factors Boulder) described a novel protein called taz1 (for teloare the proteins that bind to the duplex portion of the mere associated in Schi zosaccharomyces pombe), chromosome, best characterized in S. cerevisiae. As which was recovered from a one hybrid screen using S. components of telomeric chromatin, the yeast duplex pombe telomeric sequences linked to a reporter gene. telomere-binding protein Rap1 and its associated facDeletion of taz1 disrupts the non-nucleosomal chromators have been shown to play key roles in telomere tin structure normally present at wildtype telomeres and length regulation. However, a gene identification bottledramatically enhances the expression of a telomereneck similar to that for telomerase has also occurred proximal reporter gene, normally subject to transcripfor telomere binding proteins, in that the ciliate and S.
tional repression in taz1 ϩ cells (referred to as telomere cerevisiae genes did not readily lead to the identification position effect). The absence of taz1 function and the of their mammalian counterparts. A critical step in breakresulting disruption of telomeric chromatin also results ing this bottleneck came last year with the cloning of a in unregulated telomere elongation, with telomeres inhuman gene called TRF (Telomere Repeat Factor), using creasing in length by at least ten-fold. Intriguingly, taz1 Ϫ / a biochemical rather than a molecular approach (Chong taz1 Ϫ diploids also display a meiotic defect as maniet al., 1995) . TRF protein binds with high sequence specfested by a substantial decline in spore viability as well ificity to human duplex telomeric DNA and localizes in as an alteration in spore morphology. This may provide vivo to the telomere; by analogy with Rap1, it should be a molecular basis for understanding telomere-led chrosimilarly involved in telomere length regulation. As the mosome movement that occurs during S. pombe prefirst mammalian protein involved in telomere biology, meiosis (Chikashige et al., 1994) ; Taz1 (or Taz1-associthis should now allow rapid identification of associated ated factors) may mediate chromosome association proteins involved at the telomere. These three mammaand/or recombination during the steps leading to lian telomere genes (TRF, hTR, and mTR) have also promeiosis. vided the first opportunities for comparisons with teloThese observations in budding and fission yeast have mere length maintenance in model organisms. One of led both laboratories to propose that components of the themes of the meeting was that although fundamentelomeric chromatin wrap the telomere up into a structal concepts for telomere biology hold true from ciliates tured complex, thereby preventing unlimited access of to yeast to humans, the regulation of telomere length in telomerase to the telomere. The flip side of the coin multicellular organisms is revealing unexpected comis the question of whether there are factors that are plexities.
necessary to load telomerase onto the chromosomal terminus. V. Lundblad (Baylor College of Medicine, Houston, Texas) described a genetic search for teloTelomerase Regulation: Insights merase-defective mutants of budding yeast that led to from Model Organisms the identification of four S. cerevisiae genes that are Genetic forays into both the budding and fission yeasts required in vivo for telomerase function but dispensable have recently revealed a wealth of information about in vitro for enzymatic activity. A possible explanation for negative and positive regulation of telomerase activity.
this apparent contradiction came from the demonstraIn the budding yeast K. lactis, alterations in the setion that two of the genes identified in this screen, EST1 quence of the telomeres, via changes in the template and CDC13, encode single-strand telomere DNAregion of the telomerase RNA, had previously been binding proteins. This class of telomere-binding proshown to result in dramatic increases in telomere teins, primarily characterized in the ciliates, had prelengths. McEachern and Blackburn (1995) had proposed viously been proposed to protect the telomere from that these altered telomeres resulted in the loss of telodegradation. Indeed, prior work from Hartwell's lab mere-binding proteins, permitting unregulated access showing a critical role for CDC13 in maintaining telomere of telomerase to the chromosomal terminus. One likely integrity is consistent with a protective function (Garvik candidate for a K. lactis telomere length regulator is et al., 1995) . However, the characterization of a novel the duplex DNA-binding protein Rap1 described above.
cdc13 mutation with a telomerase-like defect in this new Consistent with this prediction, E. Blackburn (University screen led to the model that Cdc13p also provides, in of California, San Francisco, California) showed that collaboration with Est1p, a docking site for telomerase telomere sequence alterations that lead to runaway teloat the end of the chromosome, such that loss of this mere elongation in K. lactis also disrupt the Rap1 conactivity via mutation in either gene results in a telosensus site, with a loss of K. lactis Rap1 binding activity merase-minus phenotype. to mutated telomeric sequences that is proportional to Thus, factors bound to the single-strand extension the loss of length regulation observed in vivo. Furtherpresent at the extreme end of the chromosome can play more, the combination of mutant telomeres and a parseveral roles in telomere maintenance, one of which may tially defective Rap1 protein produces a striking synergistic effect: deletion of the Rap1 C-terminus in strains be to mediate telomerase access. One more observation from the K. lactis system indicates that negative regulacomplex), RF-A, and RF-C complexes share a number tion of this enzyme may also occur primarily at the chroof recognizable motifs between the human proteins and mosomal terminus. In the completely unregulated protheir yeast counterparts, with generally about 30% secess of telomere elongation that occurs in the double quence identify between the two organisms for these mutant strain described above, with a defective Rap1p sets of genes. and mutant telomeric repeats, reintroduction of one or One limited point of similarity between hTRF and Taz1 more wildtype telomeric repeats at the terminus preis the presence of one copy of the Myb proto-oncogene vents further lengthening (E. Blackburn). This indicates DNA binding motif in the C-terminus of each of these that Rap1 occupancy at the most distal duplex portion two proteins (Chong et al., 1995; T. Cech) . Although the of the telomere is critical for its role in limiting telomerase S. cerevisiae Rap1 protein has no recognizable Myb entry, and also suggests the possibility of cross-talk domains at the primary sequence level, the recently between Rap1 (and Rap1-associated factors) and prosolved crystal structure of the Rap1 DNA binding fragteins bound to the single-strand extension, such as ment revealed two domains with structural similarity to Cdc13 and Est1.
the Myb motif (Konig et al., 1996) . Myb-containing proteins require a minimum of two Myb repeats to bind DNA A Theme of Functional Conservation Only and the Rap1 DNA binding domain also has a bipartite The G-rich telomeric repeat tract exhibits striking seorganization, raising the question of how proteins such quence similarities across the eukaryotic kingdom, with as hTRF and Taz1, each with a single Myb motif, funcmany evolutionary diverse species displaying the same tion. In the case of hTRF, this was resolved via the or highly related sequences at the telomere. In every demonstration that hTRF dimerizes and thereby also case examined to date, these G-rich telomeric repeats uses two Myb-type repeats to bind DNA (T. de Lange). have been shown to be synthesized by telomerase, al-A further extension of the concept of the yeast and ways using a RNA-templated mechanism. Molecular human proteins as functional analogs is the demonstraanalysis of components of both telomerase and telotion that hTRF creates a bend of 120Њ in DNA (T. de meric chromatin has now made it possible to ask Lange), similar to that observed for Rap1. The ability to whether this functional economy reflects a similar conbend DNA raises the possibility of an architectural role servation of the various factors. Comparison of the for these nuclear matrix proteins in telomere packaging. genes encoding the RNA subunit of telomerase from a number of distantly related species had revealed little sequence identity but a common secondary structure, Complexities in Mammalian Telomere similar to what had also been observed for RNA compoLength Regulation nents of many (although not all) other RNPs. SurprisAs is almost always the case in newly emerging fields, ingly, however, the proteins that act at the telomere are the striking difference between telomerase activity in not recognizable homologs of each other, even though cancer cells versus normal cells was initially dealt with they display substantial functional similarity. The seas an all-or-none phenomenon. There is now compelling quence of the first protein components of telomerase evidence that telomerase activity is regulated at multiple became available last year (Collins et al., 1995) , approlevels in mammalian cells. As discussed above, both priately from the ciliate Tetrahymena, where enzyme double-strand and single-strand telomere binding proactivity was first identified (Greider and Blackburn, teins mediate access of telomerase to the chromosomal 1985). Perhaps not unexpectedly, these first telomerase terminus and are important contributors to telomere proteins did not identify other genes in the database. length regulation in organisms that are constitutively However, the sequence of two protein subunits from telomerase-positive. A number of speakers presented another ciliate (evolutionarily distant from Tetrahymena) data indicating that in humans there must be multiple has now been completed, and no identifiable conserved layers of complexity in which telomerase is controlled motifs can be observed between these two sets of teloby at least several different pathways that alter its activmerase proteins (T. Cech). This lack of sequence similarity and/or expression as a function of cell cycle, growth, ity has important implications for the ease with which and development. additional telomerase components from other organThe use of several different cell culture model systems isms, including humans, will be isolated; the absence demonstrated that telomerase activity undergoes subof conserved protein domains argues that extending the stantial regulation upon entry or exit from the cell cycle. set of cloned telomerase protein subunits is not going Large increases in both telomerase activity and steady to be trivial. In a similar vein, there is no detectable state hTR RNA levels are observed as normal human T conservation between the yeast and ciliate single-strand cells progress from G0 to S phase, and although telotelomere binding proteins, even in their DNA binding merase is activated around the start of S phase, inducdomains (V. Lundblad), and the three duplex telomere tion does not require DNA synthesis (K. Buchovich, Cold binding proteins (hTRF, Rap1, and Taz1) have very limSpring Harbor, New York; C.-P. Chiu, Geron Corporaited sequence similarity (Chong et al., 1995; T. Cech) . In tion, Menlo Park, California). In contrast, in actively cyfact, substantial divergence has occurred even between cling cells, telomerase activity does not vary in G1 versus the mouse and human TRF proteins, with as little as S versus G2/M stages of the cell cycle, as observed for 40% sequence identity in some regions (T. Modification of the terminus could also play a role: analshortening immediately after subcloning but which subsequently reactivated telomerase; next-generation subysis of the substrate specificity of enzyme from Tetrahymena (Greider and Blackburn, 1987) and Euplotes (T.
clones showed the same fluctuation between enzyme levels in the on and off states. The extraordinarily high Cech) demonstrated that telomerase cannot act on a blunt end, requiring a minimum of a four nucleotide percentage of temporarily telomerase-negative subclones indicates that there is a highly dynamic process overhang (T. Cech), consistent with predictions for an in vivo requirement for a 3Ј overhang for telomerase of telomerase repression, which could provide an explanation for the phenomenon of clonal attenuation docufunction (Lingner et al., 1995) . This structure may be generated in mammalian cells in a cell-cycle-regulated mented several decades ago (Martinez et al., 1978) . Reversible repression may also contribute to the process manner via a telomerase-independent mechanism, similar to that proposed to occur in yeast (Wellinger et al., of maintaining stable telomere length in these cell lines, but it remains to be determined whether this is the nor-1996).
Just as telomerase is tightly regulated during entry mal pattern used to regulate telomere length in vertebrates, or whether this represents an abnormal event into the cell cycle, many proliferating immortal cells repress telomerase when they become quiescent. This resulting from the particular mutation(s) that have occurred in these tumor cells as part of the process by repression can be reversible if quiescence is achieved by mechanisms such as confluence or serum deprivawhich they became immortal. For example, if the factors involved in telomerase repression are subject to gene tion, or permanent if G0 is attained following differentiation to a post-mitotic state (S. Holt). Interestingly, the dosage effects, the dynamic nature of this repression could be a consequence of fluctuations in chromosome association of G0 with telomerase repression does not appear to be uniform, since the basal cells of the prosploidy that might occur in subpopulations of immortal cells. tate in the castrated rat appear to be non-dividing but stay telomerase-positive for years (A. Meeker, Johns
Although telomerase RNA levels increase during tumor development, recent observations have shown that Hopkins University, Baltimore, Maryland), and some tumor lines may also exhibit telomerase activity after difinduction of the RNA component does not tightly correlate with increases in enzyme activity, suggesting a sepferentiation (L. Bestilny, The University of Calgary, Calgary, Alberta, Canada), although a basal level of cell arable level of regulation affecting other components of the enzyme (Avilion et al., 1996; Blasco et al., 1996 ; division was occurring in the populations that were analyzed. This lack of a simple correlation between prolifer- Broccoli et al., 1996) . Therefore, cloning of these other enzyme subunits, as well as potential regulators of gene ation and the presence of telomerase activity may reflect differences between tumor cells and normal stem cells expression or enzyme activity, will be necessary to fully understand the complexities of mammalian telomerase and/or the multiple routes that can lead to the G0 state.
A combination of evidence suggests that activation of regulation. Bryant Villeaponteau (Geron Corporation, Menlo Park, California) described a molecular approach telomerase in immortal cell lines involves the mutational inactivation of the pathway by which telomerase is rebased on a combination of subtractive and differential expression techniques that has led to a human candipressed in most normal somatic cells. This evidence includes the low frequency of immortalization events, date cDNA that is undetectable in telomerase-minus cells but is up-regulated in most telomerase-plus cell the repression of telomerase in hybrids between normal and immortal cells or cells from different immortalization lines. In a functional assay, expression of a portion of this transcript confers a dominant negative phenotype complementation groups (R. Reddel, Children's Medical Research Institute, New South Wales, Australia; T. Ide, on telomere length, consistent with a role for this protein in telomere length regulation, either as a component of Hiroshima University School of Medicine, Hiroshima, Japan) and the demonstration that individual chromotelomerase or possibly as a positive regulator of the enzyme. somes (3p and 1q; C. Barrett, National Institute of Environmental Health Sciences, Research Triangle Park, Finally, increasing evidence indicates that there is a separate independent pathway for telomere length North Carolina; M. Oshimura, Tottori University, Tottori, Japan) can repress telomerase in certain immortal cells.
maintenance that does not require telomerase (Kim et al., 1994; Bryan et al., 1995) . A substantial number of This strongly implies the existence of two independent mechanisms for the regulation of telomerase, since the immortalized lines have now been identified with no detectable telomerase activity and no noticeable growth postulated mutation in the pathway for the "permanent" repression of telomerase in immortal cell lines does not defects (R. Reddel; T. Ide). Strikingly, despite the absence of enzyme activity, these human cell lines are affect the ability of those cells to repress telomerase when they become quiescent. However, even in immorcharacterized by very long telomeres (up to 50 kb, approximately 30 kb longer than that observed in the lontal telomerase-positive cell lines which have presumably undergone a mutational event to allow degest telomerase-positive cell lines). This indicates an additional telomere elongation mechanism, with potenrepression of telomerase, there can still be dynamic and substantial fluctuations in the level of the enzyme. This tial similarities to telomerase-independent pathways that maintain the telomere and cell viability in budding a chromosomal end marked by an integrated plasmid marker by Southern analysis (Murnane et al., 1994) . yeast (Lundblad and Blackburn, 1993; McEachern and Blackburn, 1996) . Analysis of somatic cell hybrids beClonal analysis of a telomerase-positive cell line which is also p53 ϩ shows that telomere length varies only slightly tween telomerase-positive cell lines and cell lines exhibiting this alternative pathway raised the question of around an optimal mean length (J. Murnane, University of California, San Francisco, California), similar to the whether at least some of the genetic factors involved in the regulation of these two pathways may be shared observations described above for yeast. However, in a p53 Ϫ cell line, telomeres show substantial deviation from (R. Reddel). Of critical importance to the future use of telomerase inhibitors as an anti-cancer therapeutic is this optimal mean length, indicating that one factor involved in the genomic instability observed in p53 Ϫ cell the question of whether this alternative means of solving the end replication problem will also occur in vivo. This lines is a disruption of telomere homeostasis. correlation between very long telomeres and an alternative pathway may also relate to the discrepancy in teloTelomere Shortening in AIDS mere length that is observed between two closely reNormal T lymphocyte telomeres shorten as a function lated species of mice: M. musculus has telomere lengths of donor age in spite of telomerase activity in the hemaup to 50 kb (Kipling and Cooke, 1990; Starling et al., topoietic system. This has raised questions about 1990), whereas telomere length in the interfertile species whether cellular senescence could play a role in immune M. spretus is more in the range observed in humans failure following the increased cell turnover caused by . The availability of the mouse HIV. A significant decrease in the telomere length of telomerase RNA (Blasco et al., 1995) will provide an CD8 ϩ CD28 Ϫ T cells was found in HIV-positive patients important tool in the genetic dissection of the potential (C.-P. Chiu), although no change was found in this study contribution of this alternative pathway in vivo.
for unfractionated CD4 ϩ lymphocytes. However, it is precisely the CD4 ϩ cells that have been found to turn over the most rapidly in AIDS patients ‫%5ف(‬ per day). Another Telomere Length Homeostasis report, using many fewer patients, did find a correlation In all species studied to date, there is a species-specific between telomere length shortening in CD4 ϩ cells in determination of telomere length, and newly formed patients with rapidly progressing AIDS versus those with telomeres in a telomerase-positive cell generally match a relatively stable disease course (D. Dimitrov, National the length of bulk endogenous telomeres. However, alCancer Institute, National Institutes of Health, Bethesda, though there is an overall upper and lower limit on teloMaryland). More work is clearly needed to resolve issues mere length, a hallmark of telomeres in most species is of which lymphocytes show telomere erosion during length heterogeneity. Clonal analysis of telomere length HIV infection and whether or not cellular senescence in budding yeast showed length changes occurring for of some class of lymphocytes actually contributes to a single telomeric end (Shampay and Blackburn, 1988) , disease progression. The fact that CD4 ϩ lymphocytes suggesting that even in an organism that is constitutively do not show accelerated telomere shortening in most telomerase-positive and immortal, there is a dynamic cases raises questions of the relationship between telobalance between lengthening and shortening activities.
mere length maintenance and turnover of these cells. It In multicellular organisms, the absence of telomerase is possible that HIV-infected CD4 ϩ cells are cleared from in normal tissues is presumed to be able to eventually the circulation prior to undergoing many cell divisions; influence proliferative capacity, but telomere length hetalternatively, HIV infection may affect the functional level erogeneity raises the issue of whether there are "rateof telomerase in these cells to levels that prevent telolimiting" chromosomes with particularly short telomere shortening. Last but not least, given that accelermeres. In the murine species M. musculus, this question ated telomere shortening is observed only in CD8 ϩ cells takes on added importance, because the exceptionally fractionated based on CD28 expression, identification long telomeres in this species challenges the concept of the appropriate markers may reveal cellular senesof telomere length as a mitotic clock. One means of cence of CD4 ϩ cells. addressing this issue was provided by M. Zijlmans and P. Lansdorp (Terry Fox Laboratory, Vancover, British Columbia), who used the increased hybrid stability of
Clinical Uses of Telomerase Assays
The observation that many proliferating "stem" cells can peptide nucleic acid-DNA heteroduplexes to develop a quantitative fluorescence in situ hybridization method express telomerase raises many questions about the postulated role of cellular senescence as an anticancer for examining the telomere length of individual murine chromosomes. Preliminary findings indicate that as mechanism, the necessity of telomerase reactivation for tumor formation, and the utility of telomerase assays much as a ten-fold difference in signal could be observed between different telomeres in individual for diagnosis/prognosis. Although clear answers have not yet emerged, a large number of presentations procells; these differences were nonrandomly distributed, whereas the signal intensity between sister chromatids vided information that addressed these issues, particularly for its use in clinical applications. was highly reproducible. This suggests the opportunity in the near future to rapidly quantitate the length of A low level of telomerase activity by itself clearly does not indicate the presence of cancer. Cells of several every chromosomal terminus in individual cells, thereby greatly expanding the level of detailed information on regenerative tissues including the hematopoietic systems (K. Hiyama, Hiroshima University School of Meditelomere length control. An alternative approach to the analysis of mammalian telomere dynamics is to follow cine, Hiroshima, Japan; C.-P. Chiu; K. Buchovich; N.-P.
Weng), crypt cells in the intestine (E. Hiyama, Hiroshima California) showed that levels of hTR in neuroblastoma were as useful as telomerase levels for predicting patient University School of Medicine, Hiroshima, Japan) and the basal cells of the skin and transit amplifying cells of survival in childhood neuroblastoma. Levels of the mouse telomerase RNA component had also been the hair follicle (S. Taylor, University of Texas Southwestern Medical Center, Dallas, Texas) have been shown to shown to increase in mouse tumor models accompanying early tumor formation and hyperproliferation, even express telomerase. In lymphocytes, telomere length has been shown to shorten as a function of donor age.
before telomerase levels increased (Blasco et al., 1996; T. de Lange) . These hints that the hTR level might be This suggests a regulated activity that is sufficient to slow the rate of shortening but not completely prevent informative were confirmed by in situ hybridization studies using hTR as a probe, in which dramatic increases it, so that the proliferative capacity of these cells is extending without making them immortal. In other in signal strength were found in tumor cells versus the surrounding normal tissues (N.-W. Kim; J. Shay; E. Tacases, low levels of telomerase activity can be ascribed to the presence of activated lymphocytes (collagen lung, hara, Hiroshima University School of Medicine, Hiroshima, Japan). These initial studies found much higher systemic lupus erythematosus, dermatiomyositis, rheumatoid arthritis [K. Hiyama], psoriasis, poison ivy [S. levels in the tumor cells than in the crypts of the intestine or the germinal centers of lymph nodes (areas where Taylor], cirrhosis, chronic or acute hepatitis [H. Tahara, Hiroshima University School of Medicine, Hiroshima, Jaweak telomerase activity had previously been shown to occur due to activated lymphocytes or proliferating stem pan]). One particular interesting example was the stomach, in which 30% of normal biopsies had telomerase cells). This suggests that in situ hybridization studies using the telomerase RNA as a probe may help resolve activity (H. Tahara). However, all of these "normal" biopsies exhibited metaplasia, and approximately 75% many of the outstanding questions regarding the relative contributions of inflammatory cells, proliferating stem contained large numbers of H. pyloris, consistent with telomerase activity being contributed from both inflamcells, and tissue cellularity in the diagnosis/prognosis of tumor biopsies. matory cells and excessive proliferation of stem cells. In other examples, low level telomerase activity is likely to represent proliferating stem cells, as in chronically
Future Perspectives
The results presented at this meeting indicated that sun exposed skin (S. Taylor) or benign breast fibroadenomas (L. Gollahan, University of Texas Southwestern there are many more levels of regulation of telomerase activity and telomere length than initially suspected. Medical Center, Dallas, Texas).
Although very low levels of telomerase activity do not Analysis of the mouse and human telomerase RNA components has already shown developmental and tissuenecessarily indicate the presence of cancer cells, high levels of telomerase have been found to show significant specific regulation, as well as increased expression during tumor proliferation. As the genes encoding both the correlation with patient survival in a number of cancers, such as neuroblastoma and colon cancer (E. Hiyama) hypothesized telomerase inhibitor and protein subunits of the human enzyme are cloned, a detailed molecular and meningioma (J. Shay, University of Texas Southwestern Medical Center, Dallas, Texas). In an initial dissection of the pattern of expression of these additional components will become possible, revealing their study, telomerase levels had prognostic value for node negative but not node positive breast cancer (G. Roos, potential contributions to telomerase regulation. An additional critical experiment will be a direct in vivo test Umea University, Umea, Sweden). However, the results for node positive breast cancer were called into question of the hypothesis that telomerase reactivation is an obligatory step in oncogenesis, via genetic manipulaby Nam-Woo Kim (Geron Corporation, Menlo Park, California). Although only a very weak risk factor of about tions to ask first, if tumor progression is impaired when telomerase genes are inactivated and second, if tumor 1.4 was associated with an uncorrected telomerase level for node positive patients, the risk factor increased 20-formation can be promoted when telomerase expression is turned on in normal tissues. Crucial to the underfold if the results were normalized to a measure for viable tissue cellularity. This suggests that the already standing of these experimental alterations in telomerase expression will be a more detailed understanding of the impressive evidence that telomerase assays will have important clinical applications will likely get stronger as potential contribution of alternative telomerase-independent pathways. Finally, from the standpoint of the more sophisticated assays become used.
The complicating issues of telomerase from inflammabasic scientist, the stage is also set for a series of key experiments, including reconstitution of the enzyme tory cells, stem cells and cellularity could clearly be resolved if in situ techniques for telomerase were availfrom purified components and a molecular investigation of how telomerase interacts with components of the able. The fact that the human telomerase RNA component is expressed in normal diploid cells at 10-30% of telosome.
In spite of the complexities of telomerase regulation, the level in cancer cell lines (Avilion et al., 1996) initially discouraged its use as a probe. However, the observathe clinical reports presented at this meeting continued to support the initial enthusiasm for the diagnostic, progtion that telomerase activity is repressed in most quiescent cells but increased upon proliferation (discussed nostic, and therapeutic uses of telomerase assays and potential telomerase inhibitors. The original all-or-none above) raised the possibility that the RNA component might also be down regulated, so that the background assessment of telomerase activity in cancer versus normal cells has proven to be an oversimplification, indicatfrom quiescent normal cells might be low. C. Patrick Reynolds (Children's Hospital of Los Angeles, University ing that an increasingly sophisticated analysis of telomerase levels will be required for meaningful clinical of Southern California School of Medicine, Los Angeles,
